Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
16
NMPA:16
Drug Approvals
Ursodeoxycholic Acid Capsules
- Product Name
- 熊去氧胆酸胶囊
- Approval Number
- 国药准字H20249393
- Approval Date
- Nov 15, 2024
NMPA
Oseltamivir Phosphate for Suspension
- Product Name
- 磷酸奥司他韦干混悬剂
- Approval Number
- 国药准字H20243080
- Approval Date
- Jan 23, 2024
NMPA
Doxazosin Mesylate Extended Release Tablets
- Product Name
- 甲磺酸多沙唑嗪缓释片
- Approval Number
- 国药准字H20233964
- Approval Date
- Sep 28, 2023
NMPA
Tofacitinib Citrate Sustained-release Tablets
- Product Name
- 枸橼酸托法替布缓释片
- Approval Number
- 国药准字H20234125
- Approval Date
- Sep 5, 2023
NMPA
Rosuvastatin Calcium Tablets
- Product Name
- 瑞舒伐他汀钙片
- Approval Number
- 国药准字H20233778
- Approval Date
- Jun 27, 2023
NMPA
Atorvastatin Calcium Tablets
- Product Name
- 阿托伐他汀钙片
- Approval Number
- 国药准字H20163270
- Approval Date
- Nov 28, 2022
NMPA
Atorvastatin Calcium Tablets
- Product Name
- 阿托伐他汀钙片
- Approval Number
- 国药准字H20133127
- Approval Date
- Nov 14, 2022
NMPA
Sitagliptin Phosphate Tablets
- Product Name
- 磷酸西格列汀片
- Approval Number
- 国药准字H20223235
- Approval Date
- Apr 19, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found